AI assistant
Sending…
IMMUNIC, INC. — Director's Dealing 2020
Jul 6, 2020
10196_dirs_2020-07-06_82e89162-8ac8-428a-9ed7-1fe3c8e901b9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2020-07-02
Reporting Person: Vitt Daniel (Director, Chief Executive Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-07-02 | Stock Option | $12.30 | A | 80000 | Acquired | 2030-07-01 | Common Stock (80000) | Direct |
Footnotes
F1: 20,000 of the shares underlying the option (the "Underlying Shares") vest on the one-year anniversary of the grant date. Thereafter, 1,690 of the Underlying Shares vest on the thirteen (13) month anniversary of the grant date, and 1,666 of the Underlying Shares vest on each successive one-month anniversary thereafter for the next thirty five (35) months.
More from IMMUNIC, INC.
Regulatory Filings
2026
May 28
Board/Management Information
2026
May 27
Board/Management Information
2026
May 19
Report Publication Announcement
2026
May 13
Interim / Quarterly Report
2026
May 13
Earnings Release
2026
May 13
Regulatory Filings
2026
Apr 30
Board/Management Information
2026
Apr 28
Board/Management Information
2026
Apr 28
Share Issue/Capital Change
2026
Apr 23